AXSOME THERAPEUTICS I
90.09
08-十一月-24 14:26:29
15 分钟延时
股票
-0.61
-0.67%
今日范围
89.13 - 91.37
ISIN
N/A
来源
NASDAQ
-
Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024
08 11月 2024 06:00:28 条件 Nasdaq GlobeNewswire
-
29 10月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12
15 10月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024
24 9月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
04 9月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Participate in Investor Conferences in September
27 8月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
21 8月 2024 06:00:39 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
05 8月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5
11 7月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
05 6月 2024 06:35:00 条件 Nasdaq GlobeNewswire
-
04 6月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
03 6月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
30 5月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
29 5月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
28 5月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
08 5月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
06 5月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics Recognizes May as Mental Health Awareness Month
01 5月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
15 4月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6
10 4月 2024 06:00:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >